Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Ars Pharmaceuticals Inc (SPRY)

Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Why Shares of ARS Pharmaceuticals Are Plummeting on Wednesday Motley Fool - Wed Sep 20, 2023

The company received a Complete Response Letter from the FDA regarding its lead therapy.

SPRY : 9.75 (+3.07%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY PR Newswire - Tue May 30, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ARS Pharmaceuticals, Inc. ("ARS" or the "Company") (NASDAQ: SPRY). Such...

SPRY : 9.75 (+3.07%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY PR Newswire - Fri May 19, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ARS Pharmaceuticals, Inc. ("ARS" or the "Company") (NASDAQ: SPRY). Such...

SPRY : 9.75 (+3.07%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY PR Newswire - Wed May 10, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ARS Pharmaceuticals, Inc. ("ARS" or the "Company") (NASDAQ: SPRY). Such...

SPRY : 9.75 (+3.07%)
Is IQ Chaikin U.S. Small Cap ETF (CSML) a Strong ETF Right Now? Zacks - Mon Apr 17, 2023

Smart Beta ETF report for CSML

CSML : 34.95 (+0.71%)
SMCI : 782.70 (+2.65%)
IWM : 201.90 (+0.99%)
IJR : 107.13 (+0.75%)
IMVT : 28.86 (+0.28%)
SPRY : 9.75 (+3.07%)
Should IQ Chaikin U.S. Small Cap ETF (CSML) Be on Your Investing Radar? Zacks - Wed Apr 12, 2023

Style Box ETF report for CSML

CSML : 34.95 (+0.71%)
SMCI : 782.70 (+2.65%)
IWM : 201.90 (+0.99%)
IJR : 107.13 (+0.75%)
IMVT : 28.86 (+0.28%)
SPRY : 9.75 (+3.07%)
Is IQ Chaikin U.S. Small Cap ETF (CSML) a Strong ETF Right Now? Zacks - Mon Feb 13, 2023

Smart Beta ETF report for CSML

CSML : 34.95 (+0.71%)
SMCI : 782.70 (+2.65%)
IWM : 201.90 (+0.99%)
IJR : 107.13 (+0.75%)
IMVT : 28.86 (+0.28%)
SPRY : 9.75 (+3.07%)
Should IQ Chaikin U.S. Small Cap ETF (CSML) Be on Your Investing Radar? Zacks - Wed Feb 8, 2023

Style Box ETF report for CSML

CSML : 34.95 (+0.71%)
SMCI : 782.70 (+2.65%)
IWM : 201.90 (+0.99%)
IJR : 107.13 (+0.75%)
IMVT : 28.86 (+0.28%)
SPRY : 9.75 (+3.07%)

Barchart Exclusives

2 Uranium Stocks With 50% or More Upside Potential Barchart - 35 minutes ago
As U.S. passes the bill to ban uranium import from Russia, U.S. based uranium companies are sure to enjoy the increased demand. Here are 2 stocks with upside according to analysts. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot